Humana Names William Shrank, MD, Chief Medical Officer
January 15 2019 - 4:00PM
Business Wire
Humana Inc. (NYSE: HUM), one of the nation’s leading health and
well-being companies, announced today the appointment of William
Shrank, MD, MSHS, as Humana’s new Chief Medical Officer, effective
April 1. He will serve as a member of the Humana Management Team
and report to Humana President and CEO Bruce D. Broussard.
Dr. Shrank will succeed Roy A. Beveridge, MD, who last year
announced that he would retire from Humana in the course of 2019.
Dr. Beveridge has played a critical role over the past five and a
half years in advancing the company’s clinical strategy;
ameliorating social determinants of health for Humana members; and
leading the company’s Bold Goal initiative. To ensure a smooth
transition, Dr. Beveridge will remain with Humana for several
months after Dr. Shrank joins the firm.
As Chief Medical Officer, Dr. Shrank will play an important
leadership role in implementing the company’s integrated care
delivery strategy. This strategy emphasizes a consumer-friendly,
evidence-based, technology-enabled approach to personalized health
improvement for the company’s over 16 million Humana health plan
members.
“We’re excited to have Dr. Shrank join our team as he brings a
wide range of healthcare experiences to Humana, all of which are
complementary to our strategy,” said Broussard. “Dr. Shrank’s
background as a practicing physician, along with his experience in
integrated health systems, retail, government and academia makes
him the ideal addition to our team. His expertise in value-based
reimbursement and clinical outcomes for chronic conditions is
especially important as we advance our integrated care
strategy.”
Dr. Shrank joins Humana from the University of Pittsburgh
Medical Center (UPMC), where he served since 2016 as Chief Medical
Officer, Insurance Services Division. At UPMC, Dr. Shrank oversaw
approximately $9 billion in annual health care expenditures for
approximately 3.5 million members in Medicare, Medicaid, behavioral
health, Managed Long Term Social Supports and commercial lines of
business. He also developed and evaluated population health
programs to further advance the medical center’s mission as an
integrated delivery and financing system.
From 2013 to 2016, Dr. Shrank was Senior Vice President, Chief
Scientific Officer, and Chief Medical Officer of Provider
Innovation at CVS Health. From 2011 to 2013, Dr. Shrank served as
Director, Research and Rapid-Cycle Evaluation Group, for the Center
for Medicare and Medicaid Innovation, part of the Centers for
Medicare and Medicaid Services (CMS), where he led the evaluation
of all payment and health system delivery reform programs and
developed the rapid-cycle strategy to promote continuous quality
improvement.
Dr. Shrank began his career as a practicing physician with
Brigham and Women’s Hospital in Boston and an Assistant Professor
at Harvard Medical School. His research at Harvard focused on
improving the quality of prescribing and the use of chronic
medications. He has published more than 200 papers on these
topics.
Dr. Shrank received his M.D. from Cornell University Medical
College. He completed his residency in internal medicine at
Georgetown University and his fellowship in Health Policy Research
at the University of California, Los Angeles. He also earned a
Master of Science degree in health services from the University of
California, Los Angeles and a bachelor's degree from Brown
University.
About Humana
Humana Inc. is committed to helping our millions of medical and
specialty members achieve their best health. Our successful history
in care delivery and health plan administration is helping us
create a new kind of integrated care with the power to improve
health and well-being and lower costs. Our efforts are leading to a
better quality of life for people with Medicare, families,
individuals, military service personnel, and communities at
large.
To accomplish that, we support physicians and other health care
professionals as they work to deliver the right care in the right
place for their patients, our members. Our range of clinical
capabilities, resources and tools – such as in-home care,
behavioral health, pharmacy services, data analytics and wellness
solutions – combine to produce a simplified experience that makes
health care easier to navigate and more effective.
More information regarding Humana is available to investors via
the Investor Relations page of the company’s web site at
www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission
filings
- Most recent investor conference
presentations
- Quarterly earnings news releases and
conference calls
- Calendar of events
- Corporate Governance information
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190115005750/en/
Alex KepnesHumana Corporate Communications(502)
580-2990akepnes@humana.com
Amy SmithHumana Investor Relations(502)
580-2811Amysmith@humana.com
Humana (NYSE:HUM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Humana (NYSE:HUM)
Historical Stock Chart
From Apr 2023 to Apr 2024